Newborn screening is a public health methodology employing standardized diagnostic tests to identify specific, often rare, treatable genetic, metabolic, endocrine, and hematologic disorders in neonates before the onset of clinical symptoms. This concept involves the systematic application of analytical methods to biological samples from nearly all newborns, with the primary significance being the facilitation of early intervention to prevent severe disability, mortality, and improve long-term health outcomes.